Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Tuire Prami"'
Autor:
Kirsi Malmivaara, Mari Pölkki, Tuire Prami, Paavo Raittinen, Eija Heikkilä, Antti Aalto, Teija Dunder, Varpu Elenius, Kristina Sandström, Lisa J. McGarry
Publikováno v:
Heliyon, Vol 10, Iss 13, Pp e33439- (2024)
Background: Knowledge of prevalence and epidemiology of cystic fibrosis (CF) and healthcare resource use among Finnish people with CF is incomplete. Methods: We conducted a population-based matched cohort study using retrospective real-world data fro
Externí odkaz:
https://doaj.org/article/63c3909f175d4d0694a5395ddef4862d
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Despite currently available treatments, the burden of myocardial infarction (MI) morbidity and mortality remains prominent. The aim of this was to investigate the risk of developing subsequent cardiovascular events in MI patients.
Externí odkaz:
https://doaj.org/article/427ee48af8b443269d88b301e928edd2
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::007cef94dc4a76a927b7e5c623e9f7dd
https://doi.org/10.1530/endoabs.90.ep743
https://doi.org/10.1530/endoabs.90.ep743
Publikováno v:
European Journal of Clinical Pharmacology. 76:257-265
Purpose Use of oral antiplatelets (OAPs) is essential for preventing thrombotic events in patients with acute coronary syndrome (ACS). Effects of clopidogrel, prasugrel, and ticagrelor may be enhanced due to pharmacodynamic interactions, but as CYP s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e668f768a90b455186dd4d0a6c31173c
https://doi.org/10.1007/s00228-019-02777-z
https://doi.org/10.1007/s00228-019-02777-z
Publikováno v:
Databases for Pharmacoepidemiological Research ISBN: 9783030514549
From a pharmacoepidemiological point of view, administrative real-world register data originating from routine medical practice are essential in post-approval observational studies. Finland, Sweden, and Norway are located in the north of Europe, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5917ff7c996fa9844d2bce8a0110ae91
https://doi.org/10.1007/978-3-030-51455-6_6
https://doi.org/10.1007/978-3-030-51455-6_6
Autor:
Mikko Vahteristo, Tuire Prami, Solomon Christopher, Mikko Kuoppamäki, Pasi Korhonen, Fabian Hoti, Juha Ellmen, Valtteri V Aho, Jari Haukka, Eero Pukkala
Publikováno v:
Movement Disorders. 30:724-728
Background The association between Parkinson's disease (PD) and prostate cancer, both common in elderly men, is disputable. In the STRIDE-PD study, prostate cancer developed in 9 patients (3.7%) receiving levodopa/carbidopa with entacapone, a catecho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c760e4f29452390921a774445851e1b
https://doi.org/10.1002/mds.26140
https://doi.org/10.1002/mds.26140
Autor:
Eero Pukkala, Solomon Christopher, Jari Haukka, Pasi Korhonen, Tuire Prami, Juha Ellmen, Valtteri V Aho, Fabian Hoti, Mikko Vahteristo, Mikko Kuoppamäki
Publikováno v:
Value in Health. 17(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afa3ff37d1dcd6955a205df6437c4590
Autor:
Pasi, Korhonen, Mikko, Kuoppamäki, Tuire, Prami, Fabian, Hoti, Solomon, Christopher, Juha, Ellmén, Valtteri, Aho, Mikko, Vahteristo, Eero, Pukkala, Jari, Haukka
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 30(5)
The association between Parkinson's disease (PD) and prostate cancer, both common in elderly men, is disputable. In the STRIDE-PD study, prostate cancer developed in 9 patients (3.7%) receiving levodopa/carbidopa with entacapone, a catechol-O-methylt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::afbf3dd61f972449837d7677c6da14d5
https://pubmed.ncbi.nlm.nih.gov/25639262
https://pubmed.ncbi.nlm.nih.gov/25639262
Publikováno v:
Integrated Pharmacy Research and Practice, Vol Volume 13, Pp 9-16 (2024)
Mari Pölkki, Tuire Prami Oriola, Expert Services, Espoo, FinlandCorrespondence: Tuire Prami, Oriola Finland Oy, Orionintie 5, 02200 Espoo, Finland, Tel +358505468459, Email tuire.prami@oriola.comBackground: From the beginning of the year 2024, gradu
Externí odkaz:
https://doaj.org/article/7e83663cb3c24d0db700ce46fcaab676
Autor:
Anna Deleskog, Pål Hasvold, Eeva Reissell, Ville Kytö, Houssem Khanfir, Tuire Prami, Juhani Airaksinen
Publikováno v:
BMJ Open
Objectives To study patient selection for and persistence with ADP receptor-inhibiting oral antiplatelet (OAP) treatment after acute coronary syndrome (ACS). Design Observational, retrospective, cohort study linking real-life patient-level register d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e091f92bb525cad8b1fcdbe74a950fa
https://doi.org/10.1136/bmjopen-2016-012604
https://doi.org/10.1136/bmjopen-2016-012604